login

Incidence, prise en charge et coût des condylomes acuminés anogénitaux chez les femmes consultant leur gynécologue en France

Gynécologie Obstétrique & FertilitéPublished 1 February 2007
Joseph Monsonégo, J. Gabrielle Breugelmans, S. Bouée, A Lafuma, Stève Bénard, V. Rémy
Citations66

TL;DR

The introduction of a quadrivalent (type 6,11,16,18) Human Papillomavirus vaccine including types responsible for 90% of genital warts could potentially substantially reduce these costs.

Abstract

The costs of treating genital warts are considerable. The introduction of a quadrivalent (type 6,11,16,18) Human Papillomavirus vaccine including types responsible for 90% of genital warts could potentially substantially reduce these costs.

Keywords

Medicine